Kumar Budur

Kumar Budur

EVP and Chief Medical & Scientific OfficeratHarmony Biosciences Holdings· In proxies 2023–2025

Pay in FY2025-60% from the year before · Harmony Biosciences Holdings stock +8.7% the same year

Kumar Budur was paid $2.3M in FY2025 (Dec), down 60%. Harmony Biosciences Holdings stock rose 8.7% that year.

Pay$100 in the stock at the end of FY22 → $68
Pay is from the Summary Compensation Table of each Harmony Biosciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Harmony Biosciences HoldingsPublic company · 3 yr
    • EVP and Chief Medical & Scientific Officer2023 – Present · 3 yrStock in role -30%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?